165 related articles for article (PubMed ID: 8884021)
1. Chemical carcinogenesis, mutagenesis, and teratogenesis.
O'Brien PJ; Hales BF; Josephy PD; Castonguay A; Yamazoe Y; Guengerich FP
Can J Physiol Pharmacol; 1996 May; 74(5):565-71. PubMed ID: 8884021
[TBL] [Abstract][Full Text] [Related]
2. Environmental and chemical carcinogenesis.
Wogan GN; Hecht SS; Felton JS; Conney AH; Loeb LA
Semin Cancer Biol; 2004 Dec; 14(6):473-86. PubMed ID: 15489140
[TBL] [Abstract][Full Text] [Related]
3. Metabolism of 5-methylchrysene and 6-methylchrysene by human hepatic and pulmonary cytochrome P450 enzymes.
Koehl W; Amin S; Staretz ME; Ueng YF; Yamazaki H; Tateishi T; Guengerich FP; Hecht SS
Cancer Res; 1996 Jan; 56(2):316-24. PubMed ID: 8542586
[TBL] [Abstract][Full Text] [Related]
4. [Genetic polymorphisms in xenobiotic metabolizing enzymes as a determinant of susceptibility to environmental mutagens and carcinogens in humans].
Ozawa S
Yakugaku Zasshi; 1997 Nov; 117(10-11):895-909. PubMed ID: 9414599
[TBL] [Abstract][Full Text] [Related]
5. Metabolic activation of environmental carcinogens and mutagens by human liver microsomes. Role of cytochrome P-450 homologous to a 3-methylcholanthrene-inducible isozyme in rat liver.
Shimada T; Okuda Y
Biochem Pharmacol; 1988 Feb; 37(3):459-65. PubMed ID: 3337745
[TBL] [Abstract][Full Text] [Related]
6. Mutagenic activation of carcinogenic N-nitrosopropylamines by rat liver: evidence for a cytochrome P-450 dependent reaction.
Mori Y; Yamazaki H; Toyoshi K; Makino T; Obara T; Yokose Y; Konishi Y
Carcinogenesis; 1985 Mar; 6(3):415-20. PubMed ID: 3884171
[TBL] [Abstract][Full Text] [Related]
7. Cytochrome P450 2E1 and 2A6 enzymes as major catalysts for metabolic activation of N-nitrosodialkylamines and tobacco-related nitrosamines in human liver microsomes.
Yamazaki H; Inui Y; Yun CH; Guengerich FP; Shimada T
Carcinogenesis; 1992 Oct; 13(10):1789-94. PubMed ID: 1423839
[TBL] [Abstract][Full Text] [Related]
8. Effect of cigarette smoke on the mutagenic activation of various carcinogens in hamster.
Mori Y; Iimura K; Furukawa F; Nishikawa A; Takahashi M; Konishi Y
Mutat Res; 1995 Jan; 346(1):1-8. PubMed ID: 7530323
[TBL] [Abstract][Full Text] [Related]
9. The role of biotransformation in dietary (anti)carcinogenesis.
van Iersel ML; Verhagen H; van Bladeren PJ
Mutat Res; 1999 Jul; 443(1-2):259-70. PubMed ID: 10415444
[TBL] [Abstract][Full Text] [Related]
10. In vivo effects of N-acetylcysteine on glutathione metabolism and on the biotransformation of carcinogenic and/or mutagenic compounds.
De Flora S; Bennicelli C; Camoirano A; Serra D; Romano M; Rossi GA; Morelli A; De Flora A
Carcinogenesis; 1985 Dec; 6(12):1735-45. PubMed ID: 3905042
[TBL] [Abstract][Full Text] [Related]
11. Metabolic oxidation of the carcinogens 4-aminobiphenyl and 4,4'-methylene-bis(2-chloroaniline) by human hepatic microsomes and by purified rat hepatic cytochrome P-450 monooxygenases.
Butler MA; Guengerich FP; Kadlubar FF
Cancer Res; 1989 Jan; 49(1):25-31. PubMed ID: 2908851
[TBL] [Abstract][Full Text] [Related]
12. Effect of cigarette smoke on the mutagenic activation of environmental carcinogens by rodent liver.
Koide A; Fuwa K; Furukawa F; Hirose M; Nishikawa A; Mori Y
Mutat Res; 1999 Jul; 428(1-2):165-76. PubMed ID: 10517990
[TBL] [Abstract][Full Text] [Related]
13. Human cytochrome P-450PA (P-450IA2), the phenacetin O-deethylase, is primarily responsible for the hepatic 3-demethylation of caffeine and N-oxidation of carcinogenic arylamines.
Butler MA; Iwasaki M; Guengerich FP; Kadlubar FF
Proc Natl Acad Sci U S A; 1989 Oct; 86(20):7696-700. PubMed ID: 2813353
[TBL] [Abstract][Full Text] [Related]
14. Mechanisms of cytochrome P450 1A2-mediated formation of N-hydroxy arylamines and heterocyclic amines and their reaction with guanyl residues.
Guengerich FP; Humphreys WG; Yun CH; Hammons GJ; Kadlubar FF; Seto Y; Okazaki O; Martin MV
Princess Takamatsu Symp; 1995; 23():78-84. PubMed ID: 8844798
[TBL] [Abstract][Full Text] [Related]
15. Activation and inactivation of carcinogenic dihaloalkanes and other compounds by glutathione S-transferase 5-5 in Salmonella typhimurium tester strain NM5004.
Shimada T; Yamazaki H; Oda Y; Hiratsuka A; Watabe T; Guengerich FP
Chem Res Toxicol; 1996; 9(1):333-40. PubMed ID: 8924613
[TBL] [Abstract][Full Text] [Related]
16. Phase II enzymes and bioactivation.
Hinson JA; Forkert PG
Can J Physiol Pharmacol; 1995 Oct; 73(10):1407-13. PubMed ID: 8748931
[TBL] [Abstract][Full Text] [Related]
17. Activation of 6-aminochrysene to genotoxic products by different forms of rat liver cytochrome P450 in an O-acetyltransferase-overexpressing Salmonella typhimurium strain (NM2009).
Yamazaki H; Shimada T
Biochem Pharmacol; 1992 Sep; 44(5):913-20. PubMed ID: 1530660
[TBL] [Abstract][Full Text] [Related]
18. Oxidation of 1,2-epoxy-3-butene to 1,2:3,4-diepoxybutane by cDNA-expressed human cytochromes P450 2E1 and 3A4 and human, mouse and rat liver microsomes.
Seaton MJ; Follansbee MH; Bond JA
Carcinogenesis; 1995 Oct; 16(10):2287-93. PubMed ID: 7586124
[TBL] [Abstract][Full Text] [Related]
19. Immunochemical study on the role of different types of microsomal cytochrome P-450 in mutagenesis by chemical carcinogens.
Kawajiri K; Yonekawa H; Harada N; Noshiro M; Omura T; Tagashira Y
Cancer Res; 1980 May; 40(5):1652-7. PubMed ID: 6768451
[No Abstract] [Full Text] [Related]
20. Participation of phenobarbital-inducible cytochrome P450 in the mutagenic activation of N-nitrosopropylamines by liver and lung 9000 g fractions from five animal species and man.
Mori Y; Konishi Y
IARC Sci Publ; 1991; (105):398-403. PubMed ID: 1855888
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
